← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK SPECLT · Approved 2020-01-03

Drug application

FDA Application #

ANDA209433

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK SPECLT

Manufacturer

Glenmark Pharmaceuticals Inc., USA

First approval

2020-01-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown